Homogeneous single-label biochemical Ras activation assay using time-resolved luminescence

Analytical Chemistry
|November 22, 2011
PubMed

Insights

Researchers developed a new homogeneous assay to detect Ras protein activity, crucial for cancer research. This method uses a single label and reduces protein quantity, making it ideal for high-throughput screening of potential cancer drugs.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Ras GTP-binding proteins are frequently mutated in tumors and play a key role in cancer development.
  • Detecting Ras activity is vital for understanding cell signaling in growth and differentiation, and for developing targeted cancer therapies.
  • Existing assays for small GTPases have limitations for high-throughput screening (HTS), including multiple steps, radioactive labels, and high protein requirements.

Discussion:

  • A novel homogeneous H-Ras activity assay was developed using homogeneous quenching resonance energy transfer (QRET).
  • The QRET assay utilizes a single terbium-labeled GTP (Tb-GTP) and a soluble quencher to measure Ras activity.
  • This method allows rapid determination of Ras activity status by monitoring the protection of Tb-GTP signal upon binding to H-Ras.

Key Insights:

  • The assay requires only 60 nM of purified H-Ras protein, significantly reducing protein quantity.
  • Functionality was validated by detecting the effect of Son of Sevenless (SOS), a Ras guanine nucleotide exchange factor.
  • High signal-to-background ratios (up to 7.7) and low coefficient of variation (9.1%) were achieved, demonstrating assay robustness.

Outlook:

  • The QRET assay's efficiency and low protein requirement make it highly suitable for HTS applications.
  • This method holds potential for accelerating the discovery of novel drugs targeting small GTPases and their pathways.
  • Further optimization could enhance its utility in drug discovery pipelines for various cancers.